FDG PET/CT for assessing tumour response to immunotherapy : Report on the EANM symposium on immune modulation and recent review of the literature.
FDG PET/CT for assessing tumour response to immunotherapy : Report on the EANM symposium on immune modulation and recent review of the literature.
复制标题
FDG PET/CT评估肿瘤对免疫疗法的反应:关于免疫调节的EANM研讨会的报告和文献近期综述。
DOI:
10.1007/s00259-018-4171-4
复制
发表时间:
2019-01
影响因子:
9.1
通讯作者:
Lopci E
中科院分区:
文献类型:
--
作者:
Aide N;Hicks RJ;Le Tourneau C;Lheureux S;Fanti S;Lopci E
This paper follows the immunotherapy symposium held during the European Association of Nuclear Medicine (EANM) 2017 Annual Congress. The biological basis of the immune checkpoint inhibitors and the drugs most frequently used for the treatment of solid tumours are reviewed. The issues of pseudoprogression (frequency, timeline), hyperprogression and immune-related side effects are discussed, as well as their implications for patient management. A review of the recent literature on the use of FDG PET for assessment of immunotherapy is presented, and recommendations are provided for assessing tumour response and reporting immune-related side effects with FDG PET based on published data and experts’ experience. Representative clinical cases are also discussed.
登录
查看更多内容
DOI:
10.1038/nrc3239
发表时间:
2012-03-22
期刊:
Nature reviews. Cancer
影响因子:
--
作者:
Pardoll DM
通讯作者:
Pardoll DM
DOI:
10.1007/s00259-017-3695-3
发表时间:
2017-08
影响因子:
9.1
作者:
Lheureux S;Denoyelle C;Ohashi PS;De Bono JS;Mottaghy FM
通讯作者:
Mottaghy FM
影响因子:
3.4
作者:
Fujii T;Colen RR;Bilen MA;Hess KR;Hajjar J;Suarez-Almazor ME;Alshawa A;Hong DS;Tsimberidou A;Janku F;Gong J;Stephen B;Subbiah V;Piha-Paul SA;Fu S;Sharma P;Mendoza T;Patel A;Thirumurthi S;Sheshadri A;Meric-Bernstam F;Naing A
通讯作者:
Naing A
影响因子:
64.8
作者:
Mellman, Ira;Coukos, George;Dranoff, Glenn
通讯作者:
Dranoff, Glenn
影响因子:
11.5
作者:
Champiat, Stephane;Dercle, Laurent;Ferte, Charles
通讯作者:
Ferte, Charles